Published in
American Association for the Advancement of Science, Science Translational Medicine, 415(9), 2017
DOI: 10.1126/scitranslmed.aam8574
Links
Tools
Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH
Journal article published in 2017 by
Atze van der Pol 
,
Andres Gil,
Herman H. W. Silljé ,
Jasper Tromp,
Ekaterina S. Ovchinnikova,
Inge Vreeswijk-Baudoin,
Martijn Hoes ,
Ibrahim J. Domian,
Bart van de Sluis,
Jan M. van Deursen ,
Adriaan A. Voors,
Dirk J. van Veldhuisen,
Wiek H. van Gilst ,
Eugene Berezikov ,
Pim van der Harst
and other authors.
,
Andres Gil,
Herman H. W. Silljé ,
Jasper Tromp,
Ekaterina S. Ovchinnikova,
Inge Vreeswijk-Baudoin,
Martijn Hoes ,
Ibrahim J. Domian,
Bart van de Sluis,
Jan M. van Deursen ,
Adriaan A. Voors,
Dirk J. van Veldhuisen,
Wiek H. van Gilst ,
Eugene Berezikov ,
Pim van der Harst
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
OPLAH is cardioprotective for myocardial infarction, and its substrate 5-oxoproline is a putative circulating marker for heart failure.